NRx Pharmaceuticals, Inc. (NRXPW) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 58M |
| Enterprise Value | 50.83M |
| P/E Ratio | -3.04 |
| PEG Ratio | -0.08 |
| Price/Sales Ratio | 29.4 |
| Price/Book Ratio | -9.12 |
| Enterprise/Revenue | 26.88 |
| Enterprise/EBITDA | -2.64 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -10.7 |
| Operating Margin | -7.5 |
AD
Management Effectiveness
| Return On Assets | -2.06 |
| Return On Equity | 1.08 |
Income Statement
| Revenue | 1.23M |
| Revenue/Share | 0.07 |
| Gross Profit | 720,000 |
| EBITDA | -27.81M |
| Net Income | -28.62M |
| Diluted EPS | -1.34 |
Balance Sheet
| Total Cash | 6.71M |
| Total Cash/Share | 0.21 |
| Total Debt | 934,000 |
| Total Debt/Equity | -0.07 |
| Current Ratio | 0.29 |
| Book Value Per Share | -0.43 |
Price History
| 52-Week Change | -85.66 |
| 52-Week High | 0.16 |
| 52-Week Low | 0 |
| Moving Average 50 Days | 0.01 |
| Moving Average 200 Days | 0.06 |
Statistics
| Average Volume | 20,160 |
| Shares Outstanding | 25.48M |
| % Held by Institutions | 0.11 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
